Ann Taylor, DO
Family Medicine · Coffeyville, KSNPI 1467430454
Payments from drug & device makers
Across 161 payments — averaging $14.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$548
- AstraZeneca$404
- Sanofi-aventis U.S. LLC$180
- Johnson & Johnson$160
- Bayer$152
- GSK$151
- plus $819 from 15 others
What the payments were for
- Food & beverage$2,414100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $548 |
| AstraZeneca | 25 | $404 |
| Sanofi-aventis U.S. LLC | 13 | $180 |
| Johnson & Johnson | 12 | $160 |
| Bayer | 8 | $152 |
| GSK | 9 | $151 |
| Merck | 10 | $138 |
| Novo Nordisk | 8 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $116 |
| Lilly USA, LLC | 7 | $103 |
| E.r. Squibb & Sons, L.L.C. | 3 | $56 |
| Boehringer Ingelheim | 4 | $55 |
| Daiichi Sankyo Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Exact Sciences | 2 | $29 |
| Pfizer | 2 | $25 |
| Boston Scientific | 1 | $20 |
| Amgen | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
How this compares
$2,414 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 29 | $218 |
| Gabapentin | 12 | $202 |
| Cefdinir | 13 | $186 |
| Potassium Chloride | 16 | $186 |
| Duloxetine Hcl | 12 | $124 |
| Methylprednisolone | 12 | $85 |
| Levothyroxine Sodium | 12 | $61 |
| Furosemide | 12 | $33 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Coffeyville
- Terry PolingWichita$24.2M
- Richard GloverNewton$19.6M
- Daniel DickersonLenexa$13.6M
- Patrick YaoOlathe$11.7M
- Michael RauschAugusta$8.1M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
- Thomas KleinWichita$3.4M
- Troy HoldemanNewton$3.2M
- Stacy SlechtaNewton$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.